Pre-hospital trauma care

Stop the bleed the gauze can't.

Versil is developing an injectable, self-expanding foam that seals life-threatening wounds and stops bleeding in under 30 seconds — one-handed, in any conditions.

Get in touch How it works

<30s

to stop bleeding

cause of preventable trauma death

$3B

global hemostatics market

The problem

When bleeding can't be pressed, today's tools fall short.

Uncontrolled hemorrhage is the leading cause of preventable death after injury. For deep, noncompressible wounds — torso, groin, neck — gauze has to be packed by hand, washes out when wet, and depends on the patient still being able to clot. First responders need something faster, simpler, and more reliable.

The technology

One material that travels like a liquid and holds like a solid.

Dispensed straight into the wound, Versil's foam expands into a sponge that fills the cavity, applies outward pressure, and actively drives clotting — all at once.

Seals & clots at once

Applies pressure and triggers clotting together — working even when the patient's own blood can't clot.

One-handed, no training

No packing, no technique to learn. Reaches deep wounds that can't be packed and sets in under 30 seconds.

Works in the field

Waterproof and field-stable where gauze fails — rain, snow, or wet wounds — and removes cleanly in one piece.

Capability	Gauze	Sealants	Versil
One-handed, no packing	No	No	Yes
Works when wet	No	No	Yes
Actively triggers clotting	No	Partial	Yes
Removes cleanly	Partial	No	Yes

Representative comparison based on published performance and customer-discovery research. Versil is an investigational device in development; not yet FDA-cleared.

The team

Built by the people who invented it.

Versil is a University of Central Florida spinout, grounded in peer-reviewed materials research and shaped by direct work with the medics and responders who'll use it.

Dr. Pritha Sarkar

Co-Founder & Entrepreneurial Lead

Inventor of the core technology, leading Versil from the lab to the field.

Dr. Kausik Mukhopadhyay

Co-Founder & Principal Investigator

Materials scientist and patent co-inventor; directs UCF's Hybrid Materials Lab.

Get in touch

Partner with us.

We're talking with investors, strategic partners, and trauma-care organizations. Reach out — we'd love to tell you more.

prithasarkar@versiltech.com